ETON

Eton Pharmaceutcials, Inc. Common Stock

50.00

USD

-0.02

-0.04%

Oct 23, 15:59 UTC -4

Closed

After-Market

49.44

-0.56

-1.13%

Eton Pharmaceutcials, Inc. Common Stock (ETON) Profile

Eton Pharmaceutcials, Inc. Common Stock Profile

About

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

Info & Links

CEO

Sean E. Brynjelsen

Headquarters

21925 W. FIELD PARKWAY, SUITE 235
DEER PARK, IL 60010, UNITED STATES

Auditor

GRANT THORNTON LLP

Share holders

Employees

Eton Pharmaceutcials, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.41B

Enterprise Value

1.41B

Enterprise Value/EBITDA(ttm)

65.82

Price to Earnings Ratio(ttm)

131.63

Price to Sales(ttm)

13.54

Price to Book(mrq)

29.41

Price to Cash(ytd)

9.65K

Profitability

Gross Margin(ttm)

56.22%

Operating Margin(ttm)

12.02%

Profit Margin(ttm)

8.90%

Return on Equity(ttm)

40.13%

Return on Invested Capital(ttm)

20.06%

Return on Assets(ttm)

12.37%

Income Statement

Revenue(ttm)

105.59M

Revenue Per Share(ttm)

3.69

Gross Profit(ttm)

61.10M

EBITDA(ttm)³

21.48M

Net Income Available to Common(ttm)

12.69M

Diluted EPS(ttm)

0.38

Share Statistics

Beta (5Y Monthly)

0.90

52-Week Change

170.86%

S&P 500 52-Week Change

18.21%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

28.58M

Dividend Yield

0.00%

Float⁴

23.87M

% Held by Insiders

16.49%

% Held by Institutions

27.86%

Balance Sheet

Total Cash(mrq)

26.84M

Total Cash Per Share(mrq)

0.94

Total Debt(mrq)

27.90M

Total Debt/Equity(mrq)

59.90%

Current Ratio(mrq)

1.52%

Quick Ratio(mrq)

1.30%

Book Value Per Share(mrq)

1.65

Cash Flow

Operating Cash Flow Per Share(ytd)

0.45

Free Cash Flow(ytd)

14.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.